June 5, 2017

Biohit helps China quit smoking

Biohit's Acetium lozenge contains L-cysteine and xylitol and successfully removes acetaldehyde in a smoker's saliva.
Biohit's Acetium lozenge contains L-cysteine and xylitol and successfully removes acetaldehyde in a smoker's saliva.
Biohit/screenshot

Biohit and Chinese Chinmax Medical Systems have confirmed an agreement for the distribution of the Acetium lozenge in China.

The companies signed the contract for a preliminary period of seven years, containing a letter of intent for a joint venture arrangement and local production.

“Our new partner co-operates with more than 3 000 hospitals, smoking cessation clinics and respiratory disease clinics,” says Semi Korpela, CEO. “The product registration process has been started.”

Biohit is a globally operating Finnish biotechnology company that produces advanced services and solutions for health sector research and early diagnosis.

In a clinical trial, their product Acetium lozenge has been found to be effective in smoking cessation. It can be used to bind carcinogenic acetaldehyde in saliva to a harmless compound during smoking and to promote oral health.

Share: